HIV-associated fatigue in the era of highly active antiretroviral therapy: novel biological mechanisms?
Payne, B A I, Hateley, C L, Ong, E L C et al. · HIV medicine · 2013 · DOI
Quick Summary
This study looked at fatigue in people living with HIV who were taking modern HIV medications and had their virus under control. Surprisingly, about half of these patients still reported significant fatigue, even though their HIV was suppressed and their immune systems were recovering. The researchers found that fatigue was often linked to problems with blood pressure control (orthostatic intolerance) and previous exposure to certain older HIV medications.
Why It Matters
This research identifies dysautonomia (autonomic nervous system dysfunction) as a potential shared biological mechanism between HIV-associated fatigue and ME/CFS, opening possibilities for common therapeutic approaches. Understanding that fatigue persists despite successful viral suppression shifts focus from viral replication to metabolic and physiological dysfunction—insights directly relevant to ME/CFS pathogenesis and treatment strategies.
Observed Findings
51% of HIV-infected patients on suppressive HAART reported excessive fatigue (FIS ≥40), and 28% reported severe fatigue (FIS ≥80)
Fatigue severity did not correlate with current CD4 count, nadir CD4 count, HIV viral load, or HAART treatment status
Prior exposure to dideoxynucleoside analogue drugs was significantly associated with fatigue severity (p=0.016)
Clinical lipodystrophy syndrome was significantly associated with fatigue severity (p=0.011)
Fatigue in treated HIV infection is common and often severe despite viral suppression, suggesting mechanisms independent of active viral replication
Prior exposure to certain antiretroviral medications and metabolic complications (lipodystrophy) may contribute to fatigue through metabolic dysfunction
Dysautonomia appears to be a significant driver of fatigue in HIV infection, similar to its proposed role in ME/CFS and other chronic illnesses
Shared autonomic and metabolic dysfunction may represent a common biological basis for fatigue across HIV infection and ME/CFS, warranting integrated therapeutic approaches
Remaining Questions
What This Study Does Not Prove
This cross-sectional study cannot establish causation; the correlation between orthostatic intolerance and fatigue does not prove dysautonomia causes fatigue. The study does not directly compare treatment approaches or test interventions targeting dysautonomia. Findings in HIV patients, while suggestive, may not directly translate to ME/CFS populations due to different underlying disease mechanisms.